IJH vs XLV
iShares Core S&P Mid-Cap ETF vs Health Care Select Sector SPDR Fund
- • IJH has the lower expense ratio at 0.05% vs 0.08% for XLV.
- • XLV pays a higher dividend yield (1.60%).
Side-by-side metrics
| Metric | IJH | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.05% | 0.08% |
Dividend yield Trailing 12-month yield. | 1.15% | 1.60% |
AUM Assets under management — bigger funds are typically more liquid. | $124.33B | $40.60B |
YTD return | 13.77% | 5.74% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.00 | 0.51 |
P/E ratio | 21.86 | 29.18 |
Last price | $75.70 | $162.17 |
Inception | — | — |
Issuer | iShares | State Street |
IJH top holdings
| TWLO | Twilio Inc Class A | 0.86% |
| CRS | Carpenter Technology Corp | 0.84% |
| MKSI | MKS Inc | 0.82% |
| CW | Curtiss-Wright Corp | 0.77% |
| NVT | nVent Electric PLC | 0.75% |
| ENTG | Entegris Inc | 0.75% |
| ATI | ATI Inc | 0.74% |
| ILMN | Illumina Inc | 0.73% |
| FTI | TechnipFMC PLC | 0.73% |
| STRL | Sterling Infrastructure Inc | 0.71% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.48% |
| JNJ | Johnson & Johnson | 10.62% |
| ABBV | AbbVie Inc | 7.72% |
| UNH | UnitedHealth Group Inc | 6.56% |
| MRK | Merck & Co Inc | 5.51% |
| AMGN | Amgen Inc | 3.40% |
| TMO | Thermo Fisher Scientific Inc | 3.24% |
| ABT | Abbott Laboratories | 2.75% |
| GILD | Gilead Sciences Inc | 2.73% |
| ISRG | Intuitive Surgical Inc | 2.45% |
About IJH
IJH (iShares Core S&P Mid-Cap ETF) is Tracks the S&P MidCap 400 index. Managed by iShares, the fund carries $124.3B in assets under management, an expense ratio of 0.05%, a dividend yield of 1.15%. Its largest holding is Twilio Inc Class A (TWLO), which represents 0.9% of the portfolio. Real Estate is the fund's largest sector exposure at 7.2%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $40.6B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.60%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.5% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.